Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

GENB stock price forecast

How will GENB stock perform in 2026 and 2030?

This page primarily displays the projected price range for GENB stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of GENB, the development trends of Generate Biomedicines, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for GENB. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Generate Biomedicines, Inc.'s financial performance and industry trends to provide short-term price predictions for GENB stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year GENB stock price forecast

Price target:
17.46 USD
+31.18%
Based on 1-year price forecasts from 63 analysts, the highest estimate is 24.51 USD, while the lowest estimate is 8.41 USD.

Analyst rating for GENB

Based on ratings from 47 analysts over the past three months, the overall consensus is Hold.

Strong buy
13
Buy
10
Hold
2
Sell
9
Strong sell
13

FAQ

How has GENB's EPS performed recently?

GENB's EPS is projected to reach -- USD next quarter. Explore more Generate Biomedicines, Inc. financial data and stay up to date on the company's latest developments on the GENB stock details page.

What is the revenue forecast for GENB next quarter?

Generate Biomedicines, Inc.'s revenue is projected to reach -- USD in the next quarter. You can view Generate Biomedicines, Inc.'s revenue and earnings on the GENB stock details page.

What is the price target for GENB?

Based on analyst estimates, the most likely target price for GENB over the next 12 months is 17.46 USD, with a projected high of 24.51 USD and a projected low of 8.41 USD. To track whether this target is reached within the next year, you can view the GENB stock price chart on the GENB stock details page to check the current GENB stock price, or follow the latest developments related to GENB on the GENB Stock News page.

What is the analyst rating for GENB?

We collected ratings from 47 analysts who have evaluated GENB stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of GENB stock in 2030?

Based on price forecasts and analyses of Generate Biomedicines, Inc. from Wall Street analysts and major investment banks, GENB is projected to trade between 26.62 USD and 133.10 USD in 2030.

GENB stock chart

GENB stock details

GENB stock price change

On the last trading day, GENB stock closed at 13.31 USD, with a price change of 6.48% for the day.

Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
NASDAQ/
GENB stock price forecast